Antibody:CD47 ratio regulates macrophage phagocytosis through competitive receptor phosphorylation
Open Access
- 1 August 2021
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 36 (8) , 109587
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- National Science Foundation (DBI-1548297)
- National Institutes of Health
- National Institute of General Medical Sciences (R01 GM134137)
This publication has 66 references indexed in Scilit:
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumorsProceedings of the National Academy of Sciences, 2012
- SYNZIP Protein Interaction Toolbox: in Vitro and in Vivo Specifications of Heterospecific Coiled-Coil Interaction DomainsACS Synthetic Biology, 2012
- Crystal Structure of Fcγ Receptor I and Its Implication in High Affinity γ-Immunoglobulin BindingJournal of Biological Chemistry, 2011
- Substrate Specificity of Protein Tyrosine Phosphatases 1B, RPTPα, SHP-1, and SHP-2Biochemistry, 2011
- Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin LymphomaCell, 2010
- Structure of Signal-regulatory Protein αJournal of Biological Chemistry, 2009
- CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem CellsCell, 2009
- Cell adhesion molecules and actin cytoskeleton at immune synapses and kinapsesCurrent Opinion in Cell Biology, 2007
- The balancing act: Inhibitory Ly49 regulate NKG2D-mediated NK cell functionsSeminars in Immunology, 2006